Synergy Pharmaceuticals to Present at Two Upcoming Investor Conferences

[at noodls] – NEW YORK, Feb. 22, 2013 — Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that President and CEO Gary S. Jacob, … more

View todays social media effects on SGYPW

View the latest stocks trending across Twitter. Click to view dashboard

See who Synergy is hiring next, click here to view